A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study

Circulation. 2024 Aug 6;150(6):509-511. doi: 10.1161/CIRCULATIONAHA.124.069726. Epub 2024 Apr 9.

Affiliations

¹ Institute for Clinical and Experimental Medicine, Prague, Czech Republic (I.N., Z.T., P.I., S.G., D.M.K., T.M., V.M., J.B., Z.D., M.H., M.P., H.R.).
² Brigham and Women's Hospital and Harvard Medical School, Boston, MA (J.M.C., M.R.M.).

PMID: 38594972
DOI: 10.1161/CIRCULATIONAHA.124.069726

No abstract available

Keywords: anticoagulants; heart failure; heart-assist devices; randomized controlled trial.

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Administration, Oral
Anticoagulants* / administration & dosage
Anticoagulants* / therapeutic use
Female
Heart Failure / drug therapy
Heart Failure / therapy
Heart-Assist Devices*
Humans
Male
Middle Aged
Prospective Studies
Treatment Outcome

Substances

Anticoagulants